In 2025, Jiangyin Tianjiang Pharmaceutical Co., Ltd. and the Federation of Chinese Medicine & Acupuncture Societies of Australia (FCMA) formally signed a strategic cooperation framework agreement, initiating comprehensive collaboration in the fields of traditional Chinese medicine education, academic exchange, and promotion. The signing ceremony was attended by, among others, representatives from Tianjiang Pharmaceuticals and Mr. Liu Chijing, a representative from FCMA.

During the ceremony, representatives from Tianjiang Pharmaceuticals introduced the company’s achievements in TCM research, production, sales, and full industrial chain development, expressing strong commitment to the Australian TCM market and academic community. The cooperation will integrate FCMA’s strengths in TCM education, clinical practice, and professional resources with Tianjiang’s experience in modern TCM industry development and specialized disease solutions. Together, they will establish the “FCMA – Tianjiang Pharmaceuticals” TCM cooperation platform to support the standardized development of TCM in Australia and serve local community health needs.

Mr. Liu Chijing, a representative from FCMA, stated that the federation has long been dedicated to promoting the professionalization, standardization, and localization of TCM and acupuncture in Australia. The partnership with Tianjiang will enhancing the overall quality and influence of TCM in the region.

The signing marks the establishment of a long-term strategic partnership between the two parties. Moving forward, they plan to jointly organize TCM academic conferences and clinical seminars in Australia, promoting the implementation of the “product + service + solution” model, and supporting the compliant application and innovative development of TCM in Australia, contributing to a global community of health for all.